A Novel Point-of-Care Immunochromatographic Strip for Lumpy Skin Disease Virus: Leveraging P32-Specific Monoclonal Antibodies for Enhanced Field Surveillance
Viruses · 05.11.2026 · 18 (11) · 1229
DOI: 10.3390/v18111229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 05.11.2026. Verfasst von Jinjin Liu und 11 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2026 Hebei Provincial Project for the Introduction of Foreign Intelligence, Hebei Provincial Science and Technology Plan Project—International Science and Technology Cooperation, National Key R&D Program of China—Intergovernmental International Science and Technology Innovation Cooperation Program.
Abstract (Originalsprache)
Lumpy skin disease (LSD) is a transboundary viral disease of cattle for which rapid antigen detection could support field surveillance and outbreak investigations. This study aimed to develop and preliminarily evaluate a colloidal gold immunochromatographic strip targeting the P32 protein of lumpy skin disease virus (LSDV). Recombinant P32 proteins were expressed in Escherichia coli, and two P32-specific monoclonal antibodies, 5B1 and 7H4, were generated using hybridoma technology. Indirect ELISA with truncated P32 fragments showed that both antibodies reacted predominantly with P32-1 (amino acids 13–60), although their precise epitopes were not determined. Of four antibody combinations tested, gold-conjugated 5B1 paired with immobilized 7H4 produced the strongest test-line signal and was selected for strip development. Using recombinant His-tagged P32, the lowest concentration consistently detected in three replicate tests was 40 μg/mL, with results read after 15 min. The strip reacted with LSDV suspension and LSDV-positive skin nodule tissue, while no positive reactions were observed with the selected heterologous viral preparations or negative controls. In an evaluation of 30 bovine clinical specimens, the strip detected 9 of 11 qPCR-positive samples and correctly classified all 19 qPCR-negative samples. Using qPCR as the comparator method, positive percent agreement was 81.82% (95% CI, 48.22–97.72%), negative percent agreement was 100% (95% CI, 82.35–100%), and overall agreement was 93.33%. These findings demonstrate the feasibility of a P32-based antigen detection strip, although its diagnostic performance requires further evaluation in larger and more representative sample sets.
Förderung
- 2026 Hebei Provincial Project for the Introduction of Foreign Intelligence
- Hebei Provincial Science and Technology Plan Project—International Science and Technology Cooperation
- National Key R&D Program of China—Intergovernmental International Science and Technology Innovation Cooperation Program
Zitieren
APA
Liu, J., Sun, Y., Wang, J., Jiang, S., Feng, J., Yang, S., Guugandaa, N., Sharav, T., Tarasiuk, K., Pejsak, Z., Liu, Y., & Zhang, J. (2026). A Novel Point-of-Care Immunochromatographic Strip for Lumpy Skin Disease Virus: Leveraging P32-Specific Monoclonal Antibodies for Enhanced Field Surveillance. Viruses, 18(11), 1229. https://doi.org/10.3390/v18111229
Vancouver
Liu J, Sun Y, Wang J, Jiang S, Feng J, Yang S, et al. A Novel Point-of-Care Immunochromatographic Strip for Lumpy Skin Disease Virus: Leveraging P32-Specific Monoclonal Antibodies for Enhanced Field Surveillance. Viruses. 2026;18(11):1229. doi:10.3390/v18111229
BibTeX
@article{Liu2026,
author = {Liu, Jinjin and Sun, Ying and Wang, Jingyi and Jiang, Shuaiyu and Feng, Jiahong and Yang, Shunli and Guugandaa, Nyamdavaa and Sharav, Tumenjargal and Tarasiuk, Kazimierz and Pejsak, Zygmunt and Liu, Yongsheng and Zhang, Jie},
title = {A Novel Point-of-Care Immunochromatographic Strip for Lumpy Skin Disease Virus: Leveraging P32-Specific Monoclonal Antibodies for Enhanced Field Surveillance},
journal = {Viruses},
year = {2026},
volume = {18},
number = {11},
pages = {1229},
doi = {10.3390/v18111229}
}
EUVIMED